Use of Cysteamine in the Treatment of Cystinosis | MicrobiomeTrials← Back to trialsNCT00359684
Use of Cysteamine in the Treatment of Cystinosis
RecruitingOBSERVATIONAL
Trial Details
Enrollment target: 330 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Lysosomal Storage DiseasesCystinosis
This study is a Phase 1/2 clinical trial that will assess the safety and efficacy of enriched gene-corrected hematopoiet…
La Jolla, United StatesCompleted Sep 18, 2024
CystinosisNative Kidney
Cystinosis is a monogenic autosomal recessive lysosomal storage disease with complete penetrance, caused by a biallelic …
Bron, FranceEst. completion Dec 2027